Top movers in Tuesday's session
By Mill Chart
Last update: May 7, 2024
These stocks are moving in today's session
Top gainers
| Ticker | Change | Comment |
|---|---|---|
| NUWE | 56.24% | Exciting news for NUWELLIS INC (NASDAQ:NUWE) as its stock price surged 56.24% to $0.27 during Tuesday's session. yesterday the company released their earnings. The stock is trading 55.53% lower than a month ago. |
| PEGY | 39.66% | PINEAPPLE ENERGY INC's (NASDAQ:PEGY) shares rose 39.66% to $0.07 during Tuesday's session. In the last 3 months the share price dropped with 47.84%. |
| GRFX | 37.9% | GRAPHEX GROUP LTD-SPON ADR's (NYSEARCA:GRFX) stock price increased by 37.9% to $0.41. Shareholders saw the stock price going 46.04% lower in the past 3 months. |
| MTC | 35.62% | Investors witnessed a remarkable 35.62% rise in MMTEC INC's (NASDAQ:MTC) shares, which climbed to $3.12 during Tuesday's session. In the last month the stock gained 25.68%. |
| MSGM | 27.94% | Positive market sentiment drove MOTORSPORT GAMES INC-A's (NASDAQ:MSGM) stock price up by 27.94% to $2.9 during Tuesday's session. The company's earnings where released Yesterday. In the last year the stock lost 54.33%. |
| VINO | 27.9% | Investors witnessed a remarkable 27.9% rise in GAUCHO GROUP HOLDINGS INC's (NASDAQ:VINO) shares, which climbed to $5.96 during Tuesday's session. In the last 6 months the share price dropped with 41.67%. |
| AIRE | 27.26% | REALPHA TECH CORP's (NASDAQ:AIRE) stock price displayed strong growth, advancing 27.26% and reaching $1.09 during Tuesday's session. Yesterday the company had a press release: reAlpha Tech Corp. Completes the Acquisition of Naamche. |
| DSGN | 26.99% | Positive market sentiment drove DESIGN THERAPEUTICS INC's (NASDAQ:DSGN) stock price up by 26.99% to $4.63 during Tuesday's session. In the last 3 months the share price increased with 57.33%. |
| BVS | 26.75% | BIOVENTUS INC - A's (NASDAQ:BVS) stock price is advancing with 26.75% to a price of $5.07. Earlier today the company had a press release: Bioventus Reports First Quarter Financial Results. |
| JMIA | 26.33% | JUMIA TECHNOLOGIES AG-ADR's (NYSE:JMIA) shares rose 26.33% to $6.91. JUMIA TECHNOLOGIES AG-ADR released earnings Yesterday. In the last 3 months the share price increased with 67.79%. |
For the full top gainers list go to our top gainers page.
Today's top losers
| Ticker | Change | Comment |
|---|---|---|
| STIM | -33.61% | Investors witnessed a 33.61% drop in NEURONETICS INC's (NASDAQ:STIM) stock price, which closed at $2.49 during Tuesday's session. NEURONETICS INC released earnings Yesterday. In the last 6 months the share price increased with 195.0%. |
| RGF | -31.93% | Investors witnessed a 31.93% decrease in REAL GOOD FOOD CO INC/THE's (NASDAQ:RGF) stock price, which closed at $0.54 during Tuesday's session. The stock is trading 120.0% higher than a month ago. |
| SGE | -27.13% | The market experienced a downward movement in STRONG GLOBAL ENTERTAINMEN-A's (NYSEARCA:SGE) stock price, closing at $1.93 with a 27.13% decrease during Tuesday's session. The stock is trading 101.0% higher than a month ago. |
| AGRI | -27.08% | AGRIFORCE GROWING SYSTEMS LT's (NASDAQ:AGRI) shares fell 27.08% to $0.11. AGRIFORCE GROWING SYSTEMS LT is releasing earnings today. Shareholders saw the stock price going 39.58% lower in the past 3 months. |
| JELD | -25.73% | JELD-WEN HOLDING INC's (NYSE:JELD) stock price is declining with 25.73% to a price of $14.14. Shareholders saw the stock price going 33.15% higher is the past 6 months. |
| HSDT | -23.97% | HELIUS MEDICAL TECHNOLOGIES's (NASDAQ:HSDT) stock price encountered a 23.97% decline, reaching $1.84 during Tuesday's session. Today NASDAQ:HSDT is releasing earnings. The stock is trading 60.39% lower than a month ago. |
| BYON | -21.15% | There was a notable decline in BEYOND INC's (NYSE:BYON) shares, as they dropped 21.15% to $17.26 during Tuesday's session. Yesterday the company had a press release: Beyond, Inc. Reports First Quarter 2024 Financial Results. |
| ALLR | -18.88% | The market experienced a downward movement in ALLARITY THERAPEUTICS INC's (NASDAQ:ALLR) stock price, closing at $0.73 with a 18.88% decrease during Tuesday's session. A press release (Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock) was released earlier today. |
| LYRA | -18.54% | LYRA THERAPEUTICS INC's (NASDAQ:LYRA) stock price is declining with 18.54% to a price of $0.42. The company's earnings where released Yesterday. In the last month the share price dropped with 89.77%. |
| SGD | -18.09% | SAFE & GREEN DEVELOPMENT COR's (NASDAQ:SGD) stock price is declining with 18.09% to a price of $0.41. A press release (Safe and Green Development Corporation to Acquire MyVonia, a Cutting-Edge AI Asset) was released earlier today. |
Our top losers page will show you the full list.
DESIGN THERAPEUTICS INC
NASDAQ:DSGN (5/31/2024, 7:00:00 PM)
After market: 4.06 +0.01 (+0.25%)4.05
+0.11 (+2.79%)
DSGN News
9 days ago - InvestorPlaceThe 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit GainsBiotechs can see triple-digit returns or dramatic losses but these Piper Sandler stocks have the potential to achieve them.
23 days ago - InvestorPlaceDSGN Stock Earnings: Design Therapeutics Beats EPS for Q1 2024DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
23 days ago - BusinessInsiderDSGN Stock Earnings: Design Therapeutics Beats EPS for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Design Therapeutics (NASDAQ:DSGN) just reported results for the first quarter o...
24 days ago - Design Therapeutics, Inc.Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program MilestonesAdvancing DT-216P2, New Drug Product for Friedreich Ataxia (FA), Toward Clinical Trials Starting Phase 1 Development for Fuchs Endothelial Corneal...
25 days ago - Design Therapeutics, Inc.Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare ConferenceCARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious...
2 months ago - Market News VideoWednesday 3/27 Insider Buying Report: SNPS, DSGN2 months ago - InvestorPlaceDSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
2 months ago - BusinessInsiderDSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Design Therapeutics (NASDAQ:DSGN) just reported results for the fourth quarter ...
2 months ago - Design Therapeutics, Inc.Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial ResultsNew Drug Product for Friedreich Ataxia (FA) DT-216P2 with Favorable Nonclinical Pharmacokinetic and Injection Site Safety Profile; Complete GLP Studies by...
